A review of systemic nonspecific immunosuppressive treatment of multiple sclerosis
Citation Manager Formats
Make Comment
See Comments
![Loading Loading](https://n.neurology.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Abstract
This article is a critical review of the literature about the effects of systemic immunosuppression on patients with multiple sclerosis. Azathioprine (or 6-mercaptopurine), chlorambucil, cyclophosphamide, levamisole, melphalan, podophyllin and other drugs by themselves and in combination therapies with adrenocortical steroids, thoracic duct drainage, and antilymphocyte sera or globulins are discussed. A decrease in frequency of relapses, rate of progression, cerebrospinal fluid gamma globulin and oligoclones, and in cerebrospinal fluid pleocytosis can be achieved, at least temporarily, by certain treatments. Lack of appropriate controls makes it difficult to evaluate these results. Therefore, immunosuppressive therapy of multiple sclerosis should be considered highly experimental. Systemic immunosuppression is difficult to achieve and maintain, has a high incidence of side effects, and the long-term consequences are not well established. More studies of drug combinations, with stratification of patients and with follow-up observations for at least 5 years, will be necessary before firm conclusions can be reached. Controlled studies of cyclophosphamide or azathioprine might be started now but other modalities also might be used in exploratory or pilot studies. These studies will require a significant investment by patients, biomedical personnel, and funding agencies, and should not be entered into casually.
- © 1978 by the American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sharon Poisson and Dr. Tiffany Brown
► Watch
Related Articles
- No related articles found.